Kevin J. Yarema
Affiliations: | Johns Hopkins University, Baltimore, MD |
Area:
Biomedical EngineeringWebsite:
https://engineering.jhu.edu/faculty/kevin-yarema/Google:
"Kevin Jon Yarema" OR "Kevin J. Yarema"Bio:
Yarema, Kevin J. (Kevin Jon) Cellular responses to platinum-based anticancer drugs Thesis (Ph. D.)--Massachusetts Institute of Technology, Dept. of Chemistry, 1994.
Parents
Sign in to add mentor| John M. Essigmann | grad student | 1994 | MIT (Chemistry Tree) | |
| (Cellular responses to platinum-based anticancer drugs) | ||||
| Carolyn R. Bertozzi | post-doc | UC Berkeley (Chemistry Tree) | ||
Children
Sign in to add trainee| Michael Murrell | research assistant | Johns Hopkins (BME Tree) | |
| Michael A. Meledeo | grad student | 2009 | Johns Hopkins |
| Srinivasa-Gopalan Sampathkumar | post-doc | 2003-2007 | (Chemistry Tree) |
| Christian Agatemor | post-doc | 2018-2021 | Johns Hopkins (Chemistry Tree) |
BETA: Related publications
See more...
Publications
|
You can help our author matching system! If you notice any publications incorrectly attributed to this author, please sign in and mark matches as correct or incorrect. |
| Dammen-Brower K, Tan E, Almaraz RT, et al. (2023) Protocol Considerations for In Vitro Metabolic Glycoengineering of Non-Natural Glycans. Current Protocols. 3: e822 |
| Saeui CT, Shah SR, Fernandez-Gil BI, et al. (2023) Anticancer Properties of Hexosamine Analogs Designed to Attenuate Metabolic Flux through the Hexosamine Biosynthetic Pathway. Acs Chemical Biology |
| Ludwig SD, Bernstein ZJ, Agatemor C, et al. (2022) A versatile design platform for glycoengineering therapeutic antibodies. Mabs. 14: 2095704 |
| Du J, Liu X, Yarema KJ, et al. (2022) Glycoengineering human neural stem cells (hNSCs) for adhesion improvement using a novel thiol-modified N-acetylmannosamine (ManNAc) analog. Materials Science & Engineering. C, Materials For Biological Applications. 112675 |
| Du J, Agatemor C, Saeui CT, et al. (2021) Glycoengineering Human Neural and Adipose Stem Cells with Novel Thiol-Modified -Acetylmannosamine (ManNAc) Analogs. Cells. 10 |
| Stabach PR, Zimmerman K, Adame A, et al. (2020) Improving the Pharmacodynamics and In Vivo Activity of ENPP1-Fc Through Protein and Glycosylation Engineering. Clinical and Translational Science |
| Saeui CT, Cho KC, Dharmarha V, et al. (2020) Cell Line-, Protein-, and Sialoglycosite-Specific Control of Flux-Based Sialylation in Human Breast Cells: Implications for Cancer Progression. Frontiers in Chemistry. 8: 13 |
| Agatemor C, Buettner MJ, Ariss R, et al. (2019) Exploiting metabolic glycoengineering to advance healthcare. Nature Reviews. Chemistry. 3: 605-620 |
| Saeui CT, Nairn AV, Galizzi M, et al. (2018) Integration of genetic and metabolic features related to sialic acid metabolism distinguishes human breast cell subtypes. Plos One. 13: e0195812 |
| Kim H, Shin K, Park OK, et al. (2017) General and Facile Coating of Single Cells via Mild Reduction. Journal of the American Chemical Society |